Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment
- PMID: 17244553
- DOI: 10.1016/j.nec.2006.10.006
Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment
Abstract
Platelet-derived growth factor (PDGF) is a growth factor family of ligands and receptors known to activate phosphatidylinositol 3-kinase, mitogen-activated protein kinase, Jak family kinase, Src family kinase, and phospholipase Cgamma signal transduction pathways, some of which have been causally linked to glioma formation. Extensive involvement of PDGF in development and its implication in a variety of pathologic conditions, including gliomagenesis, are mediated not only by autocrine effects but by paracrine effects. Many researchers view brain tumors as clonal entities derived from the cancer stem cell; however, recent documentation of the importance of the tumor microenvironment for glioma initiation and progression as well as the ability of neural stem or progenitor cells to migrate toward the sites of injury or tumor formation reveals additional complexities in brain tumorigenesis. Paracrine effects of PDGF in animal models of gliomagenesis, continued adult neurogenesis capable of increasing in response to brain injury, and the growth factor-rich environment of brain tumors suggest that recruitment may play a role in gliomagenesis. In this view, glioma formation involves recruitment of cells from the adjacent brain and possibly other sites.
Similar articles
-
Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.Mol Cancer Res. 2007 Sep;5(9):891-7. doi: 10.1158/1541-7786.MCR-07-0113. Mol Cancer Res. 2007. PMID: 17855658
-
Platelet-derived growth factor in human glioma.Glia. 1995 Nov;15(3):257-63. doi: 10.1002/glia.440150307. Glia. 1995. PMID: 8586462 Review.
-
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.Cancer Res. 2004 Jul 15;64(14):4783-9. doi: 10.1158/0008-5472.CAN-03-3831. Cancer Res. 2004. PMID: 15256447
-
Platelet-derived growth factor (PDGF) and glial tumorigenesis.Cancer Lett. 2006 Feb 8;232(2):139-47. doi: 10.1016/j.canlet.2005.02.002. Epub 2005 Aug 31. Cancer Lett. 2006. PMID: 16139423 Review.
-
Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging.Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11334-7. doi: 10.1073/pnas.0402716101. Epub 2004 Jul 23. Proc Natl Acad Sci U S A. 2004. PMID: 15273287 Free PMC article.
Cited by
-
Unique microenvironmental responses to PDGF stimulation in brain and spinal cord gliomas determine tumor phenotype.J Neurooncol. 2015 May;123(1):27-33. doi: 10.1007/s11060-015-1769-2. Epub 2015 Apr 14. J Neurooncol. 2015. PMID: 25868602
-
Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes.Cell Rep. 2016 Jun 21;15(12):2616-24. doi: 10.1016/j.celrep.2016.05.042. Epub 2016 Jun 9. Cell Rep. 2016. PMID: 27292647 Free PMC article.
-
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.Pharmaceuticals (Basel). 2021 Jun 29;14(7):626. doi: 10.3390/ph14070626. Pharmaceuticals (Basel). 2021. PMID: 34209513 Free PMC article. Review.
-
Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.J Exp Clin Cancer Res. 2022 Apr 12;41(1):139. doi: 10.1186/s13046-022-02333-1. J Exp Clin Cancer Res. 2022. PMID: 35414102 Free PMC article.
-
Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.Sci Rep. 2018 Jan 19;8(1):1180. doi: 10.1038/s41598-018-19451-6. Sci Rep. 2018. PMID: 29352201 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous